A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Mechanism of action of brexpiprazole: comparison with aripiprazole
2016
CNS Spectrums
Brexpiprazole is a new therapeutic agent that was recently approved for the treatment of schizophrenia and for the adjunctive treatment of major depressive disorder. Brexpiprazole has features that both overlap and contrast with a related molecule, aripiprazole, and these features are discussed here.
doi:10.1017/s1092852915000954
pmid:26899451
fatcat:jevjbvz6fvdtlcmwzmx3pkmn2m